Zuhal Reed, Esq. | Risk Management Senior Staff Attorney | Medmarc
November 19, 2021
The U.S. Food and Drug Administration (FDA) has come together with other international Public Health counterparts to outline a set of ten guiding principles related to medical devices that use artificial intelligence and machine learning (AI/ML). FDA, Health Canada, and the United Kingdom’s Medicines and Healthcare Products Regulatory Agency (MHRA) have set forth these guiding principles in order to support the implementation of uniform global Good Machine Learning Practice (GMLP). GMLP is a set of quality guidelines and regulations that should be followed when implementing machine learning. The FDA’s adoption of these guidelines in unison with other relevant international regulatory bodies signals FDA’s concerted efforts to highlight the importance of international harmonization of GMLP. The guiding principles are intended to “promote safe, effective, and high-quality medical devices that use artificial intelligence and machine learning (AI/ML).”
AI/ML medical devices make use of a relatively new technology that regulatory bodies are grappling with globally. The new guidance document touches on the real value in medical devices using AI/ML and the capability of these devices to deduce information from enormous sets of real-world data generated through daily use. The ten principles identified in the document should be central to the advancement of GMLP by International Medical Device Regulators Forum (IMDRF), international standards organizations, and other collaborative bodies. Below are the ten guiding principles to be set out in the document[1].
It is important to keep in mind that this document is not binding law. Rather, it is a guiding tool that should be used in the design, testing, and manufacturing of your AI/ML medical devices. Compliance with the document becomes particularly important if you are aiming to distribute your AI/ML medical device globally across several markets.
For additional resources contact the Marketing department
Phone: 888-633-6272
Copyright © 2022 - Medmarc
All statements and opinions in this publication are for informational and educational purposes only. None of the information presented should be considered as offering legal advice or legal opinion. We are not liable for any errors, inaccuracies or omissions. In the event any of the information presented conflicts with the terms and conditions of any policy of insurance offered by Medmarc Insurance Group, the terms and conditions of the actual policy will apply.